Maxigen Biotech Inc. (1783.TW)

TWD 46.3

(-0.43%)

Gross Profit Summary of Maxigen Biotech Inc.

  • Maxigen Biotech Inc.'s latest annual gross profit in 2023 was 424.09 Million TWD , up 13.4% from previous year.
  • Maxigen Biotech Inc.'s latest quarterly gross profit in 2024 Q2 was 116.19 Million TWD , up 32.62% from previous quarter.
  • Maxigen Biotech Inc. reported a annual gross profit of 373.99 Million TWD in annual gross profit 2022, up 43.28% from previous year.
  • Maxigen Biotech Inc. reported a annual gross profit of 261.02 Million TWD in annual gross profit 2021, up 21.68% from previous year.
  • Maxigen Biotech Inc. reported a quarterly gross profit of 116.19 Million TWD for 2024 Q2, up 32.62% from previous quarter.
  • Maxigen Biotech Inc. reported a quarterly gross profit of 108.62 Million TWD for 2023 Q3, down -6.54% from previous quarter.

Annual Gross Profit Chart of Maxigen Biotech Inc. (2023 - 2009)

Historical Annual Gross Profit of Maxigen Biotech Inc. (2023 - 2009)

Year Gross Profit Gross Profit Growth
2023 424.09 Million TWD 13.4%
2022 373.99 Million TWD 43.28%
2021 261.02 Million TWD 21.68%
2020 214.52 Million TWD -1.27%
2019 217.27 Million TWD 19.01%
2018 182.56 Million TWD 13.9%
2017 160.28 Million TWD 18.8%
2016 134.91 Million TWD 47.4%
2015 91.53 Million TWD -4.72%
2014 96.07 Million TWD -10.39%
2013 107.2 Million TWD 5.56%
2012 101.56 Million TWD 99.24%
2011 50.97 Million TWD -20.97%
2010 64.49 Million TWD -18.39%
2009 79.02 Million TWD 0.0%

Peer Gross Profit Comparison of Maxigen Biotech Inc.

Name Gross Profit Gross Profit Difference
Nang Kuang Pharmaceutical Co., Ltd. 755.56 Million TWD 43.87%
SciVision Biotech Inc. 512.49 Million TWD 17.249%
Bionime Corporation 715.65 Million TWD 40.74%
Pegavision Corporation 3.57 Billion TWD 88.124%
Visco Vision Inc. 857.15 Million TWD 50.523%